The Food and Drug Administration is urging pharmaceutical companies to make public data from clinical trials.
About three in 10 studies deemed highly likely to fall under mandatory reporting requirements have no results filed with the government’s clinical trial website, the FDA said on April 13. That is in line with historical estimates.
The FDA sent more than 2,200 companies and researchers messages in late March that reminded them of the requirements, the agency said on April 13.
“Far too often, companies are suppressing unfavorable clinical trial results and keeping them secret from patients and the scientific community. Those sponsoring clinical trials have an ethical obligation to make results public regardless of the data’s influence on the company’s share price,” FDA Commissioner Dr. Marty Makary said in a statement….